Medicare Enrolled
Dr. Frederick Taylor, MD
Urology Physician · London, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Taylor from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Taylor?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Taylor
Dr. Frederick Taylor is an urology physician in London, OH, with 17 years of NPI registration. Based on federal Medicare data, Dr. Taylor performed 2,991 Medicare services across 1,103 unique beneficiaries.
Between the years covered by Open Payments, Dr. Taylor received a total of $4,370 from 36 pharmaceutical and/or device companies across 180 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Taylor is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 18% volume in OH
$4,370 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,991
Medicare services
Top 18% in OH for urology physician
1,103
Unique beneficiaries
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~176 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,200 | $0 | $2 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
335 | $85 | $272 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
327 | $45 | $182 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
190 | $52 | $174 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
188 | $46 | $185 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
86 | $8 | $32 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
78 | $7 | $122 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
70 | $34 | $140 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
64 | $3 | $7 |
| PSA test (prostate cancer screening) | 64 | $18 | $69 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
53 | $98 | $397 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
45 | $39 | $2,269 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
44 | $36 | $140 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
38 | $54 | $430 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
26 | $16 | $74 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
24 | $25 | $96 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
17 | $121 | $828 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
16 | $164 | $708 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
15 | $3 | $151 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
15 | $110 | $495 |
| Sex hormone binding globulin level test A blood test that measures the level of sex hormone binding globulin, a protein that binds to sex hormones in the bloodstream. |
15 | $21 | $90 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
13 | $135 | $1,306 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
12 | $91 | $428 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
12 | $175 | $1,253 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
11 | $160 | $2,984 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
11 | $57 | $269 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
11 | $21 | $95 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
11 | $2 | $12 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
44.7% medium
54.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,370
Total received (2018-2024)
Avg $624/year across 7 years
Top 33% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
180
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,281 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$88 (2.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,003
2023
$157
2022
$886
2021
$384
2020
$332
2019
$931
2018
$677
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$420
Endo USA, Inc.
$164
Myriad Genetic Laboratories, Inc.
$162
ABBVIE INC.
$73
Endo Pharmaceuticals Inc.
$47
PFIZER INC.
$28
Dendreon Pharmaceuticals LLC
$24
VERTEX PHARMACEUTICALS INCORPORATED
$20
UROGEN PHARMA, INC.
$18
COLOPLAST CORP
$18
Antares Pharma, Inc.
$15
Merck Sharp & Dohme LLC
$14
Top 3 companies account for 74.3% of 2024 payments
All-time payments by company (2018-2024) ›
Teleflex LLC
$686
Astellas Pharma US Inc
$491
Sumitomo Pharma America, Inc.
$457
Boston Scientific Corporation
$447
Endo Pharmaceuticals Inc.
$421
NeoTract Inc.
$372
Coloplast Corp
$200
Antares Pharma, Inc.
$190
Endo USA, Inc.
$164
Myriad Genetic Laboratories, Inc.
$162
Janssen Biotech, Inc.
$79
ABBVIE INC.
$73
Myovant Sciences Inc.
$73
UROVANT SCIENCES INC
$64
Medtronic USA, Inc.
$64
Rochester Medical Corporation
$45
Ferring Pharmaceuticals Inc.
$34
C. R. BARD, INC. & SUBSIDIARIES
$30
PFIZER INC.
$28
Dendreon Pharmaceuticals LLC
$24
BOSTON SCIENTIFIC CORPORATION
$24
UroGen Pharma, Inc.
$23
VERTEX PHARMACEUTICALS INCORPORATED
$20
Blue Earth Diagnostics Limited
$19
UROGEN PHARMA, INC.
$18
COLOPLAST CORP
$18
AbbVie, Inc.
$17
Avadel Specialty Pharmaceuticals, LLC
$16
Amgen Inc.
$15
MEDIVATION FIELD SOLUTIONS LLC
$15
AbbVie Inc.
$15
Supernus Pharmaceuticals, Inc.
$14
Merck Sharp & Dohme LLC
$14
Laborie Medical Technologies Corp.
$13
Aytu BioScience, Inc
$11
Clarus Therapeutics Inc.
$11
Top 3 companies account for 37.4% of all-time payments
Associated products mentioned in payments ›
AMS · AVEED · BOTOX · CONTINENCE CARE · Erleada · GEMTESA · GENERAL ERECTILE DYSFUNCTION · General - Erectile Dysfunction · ICEfx Cryoablation System · ICONSYNC · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · Lupron Depot · MYRBETRIQ · NOCDURNA · Natesto · Noctiva · ORGOVYX · OTREXUP · Otrexup · POSLUMA · PROLARIS · PROVENGE · Prolia · SPEEDICATH · SpaceOAR VUE System - 10mL · SpeediCath · Titan · UROLIFT · UroLift · UroLift System · XIAFLEX · XTANDI · XYOSTED
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
62
Per 100K population
140.5
County median income
$83,229
Nearest hospital
MADISON HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Taylor is a clinical cardiology specialist, with above-average Medicare volume (top 18% in OH), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Taylor experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Taylor performed 1,200 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Taylor receive payments from pharmaceutical companies?
Yes. Dr. Taylor received a total of $4,370 from 36 companies across 180 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Taylor's costs compare to other urology physicians in London?
Dr. Taylor's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Taylor) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in London
Browse urology physicians in London ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology